Noninvasive Ventilation via Philips Respironics Trilogy 100 Reduces COPD Readmission Rates, Royal Philips Study Shows

Patrícia Silva, PhD avatar

by Patrícia Silva, PhD |

Share this article:

Share article via email
COPD clinical trials

A new study titled, “Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease,” currently published in the Journal of Clinical Sleep Medicinesuggests non-invasive ventilation plays a crucial role in administering effective multi-faceted patient care to COPD patients, leading to a reduction in readmission rates.

The study was backed and co-authored by Netherlands-based Royal Philips, a diversified health and well-being company specialized in improving people’s lives through advancements in the areas of Healthcare, Consumer Lifestyle and Lighting. Researchers assessed COPD patients who have been admitted to a hospital at least twice in one year and were transitioned into a COPD management program, which entailed them to receive noninvasive positive pressure ventilation (NIPPV). They found that by administering NIPPV via Philips Respironics Trilogy 100, readmission rates dropped by 97% over the following 12 months.

There has been significant pressure on health facilities across the US to actively strive for a reduction in COPD readmission rates, as these repeated hospitalizations can be quite burdensome for many patients, with estimates showing a projected nationwide cost worth $29.5 billion. Readmission rates within a month of discharge have been reported to be as much as 22.6%. This study revealed that NIPPV delivered via Philips Respironics Trilogy 100 was able to reduce readmission rates from 100% (397 out of 397) to 2.2% (9 out of 397) in the year following intervention.

“The results of this study indicate that Philips Trilogy with an advanced mode of ventilation AVAPs-AE therapy – in combination with respiratory therapist-led care, medication reconciliation and adequate provision of oxygen therapy – assisted in stabilizing the respiratory condition of patients with COPD,” said Amy Day, RRT, Director of Ventilation Management of Barnes Healthcare Services. “Such better management of the COPD condition allows health systems to not only significantly reduce readmissions and the associated high costs, but also improve the quality of life for some of its most complex patients.”

“This study holds promise in how a multi-faceted intervention could assist health systems in significantly improving the care of the patients with advanced stage COPD in their home,” said Sairam Parthasarathy, MD, Professor of Medicine and Director of the Center for Sleep Disorders at Banner – University Medical Center Tucson. “The results indicate that patients placed on this advanced mode of non-invasive ventilation, combined with an in-home care program, can reduce hospitalizations and subsequently reduce healthcare utilization. This study is a good foundation to build from and to further validate.”